The Joint Statistics
Total Valuation
The Joint has a market cap or net worth of $151.46 million. The enterprise value is $131.53 million.
Important Dates
The next estimated earnings date is Thursday, May 1, 2025, after market close.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
The Joint has 15.32 million shares outstanding. The number of shares has increased by 3.13% in one year.
Current Share Class | 15.32M |
Shares Outstanding | 15.32M |
Shares Change (YoY) | +3.13% |
Shares Change (QoQ) | -0.10% |
Owned by Insiders (%) | 2.89% |
Owned by Institutions (%) | 45.95% |
Float | 10.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 62.28 |
PS Ratio | 2.82 |
Forward PS | 1.98 |
PB Ratio | 8.29 |
P/TBV Ratio | 8.71 |
P/FCF Ratio | 18.97 |
P/OCF Ratio | 16.58 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 571.22, with an EV/FCF ratio of 15.98.
EV / Earnings | n/a |
EV / Sales | 2.53 |
EV / EBITDA | 571.22 |
EV / EBIT | n/a |
EV / FCF | 15.98 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.02.
Current Ratio | 1.46 |
Quick Ratio | 0.56 |
Debt / Equity | 0.02 |
Debt / EBITDA | 0.92 |
Debt / FCF | 0.05 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.20% and return on invested capital (ROIC) is -3.08%.
Return on Equity (ROE) | -7.20% |
Return on Assets (ROA) | -0.85% |
Return on Invested Capital (ROIC) | -3.08% |
Return on Capital Employed (ROCE) | -3.65% |
Revenue Per Employee | $70,512 |
Profits Per Employee | -$11,589 |
Employee Count | 736 |
Asset Turnover | 0.62 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, The Joint has paid $62,142 in taxes.
Income Tax | 62,142 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.02% in the last 52 weeks. The beta is 1.46, so The Joint's price volatility has been higher than the market average.
Beta (5Y) | 1.46 |
52-Week Price Change | -20.02% |
50-Day Moving Average | 11.25 |
200-Day Moving Average | 11.49 |
Relative Strength Index (RSI) | 34.94 |
Average Volume (20 Days) | 81,098 |
Short Selling Information
The latest short interest is 397,243, so 2.59% of the outstanding shares have been sold short.
Short Interest | 397,243 |
Short Previous Month | 375,927 |
Short % of Shares Out | 2.59% |
Short % of Float | 3.63% |
Short Ratio (days to cover) | 4.98 |
Income Statement
In the last 12 months, The Joint had revenue of $51.90 million and -$8.53 million in losses. Loss per share was -$0.57.
Revenue | 51.90M |
Gross Profit | 40.38M |
Operating Income | -1.13M |
Pretax Income | -3.34M |
Net Income | -8.53M |
EBITDA | 230,269 |
EBIT | -1.13M |
Loss Per Share | -$0.57 |
Full Income Statement Balance Sheet
The company has $25.05 million in cash and $448,285 in debt, giving a net cash position of $24.60 million or $1.61 per share.
Cash & Cash Equivalents | 25.05M |
Total Debt | 448,285 |
Net Cash | 24.60M |
Net Cash Per Share | $1.61 |
Equity (Book Value) | 17.95M |
Book Value Per Share | 1.18 |
Working Capital | 22.84M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $9.42 million and capital expenditures -$1.19 million, giving a free cash flow of $8.23 million.
Operating Cash Flow | 9.42M |
Capital Expenditures | -1.19M |
Free Cash Flow | 8.23M |
FCF Per Share | $0.54 |
Full Cash Flow Statement Margins
Gross margin is 77.81%, with operating and profit margins of -2.18% and -16.44%.
Gross Margin | 77.81% |
Operating Margin | -2.18% |
Pretax Margin | -2.84% |
Profit Margin | -16.44% |
EBITDA Margin | 0.44% |
EBIT Margin | -2.18% |
FCF Margin | 15.86% |
Dividends & Yields
The Joint does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.13% |
Shareholder Yield | -3.13% |
Earnings Yield | -5.46% |
FCF Yield | 5.27% |
Analyst Forecast
The average price target for The Joint is $17.50, which is 77.04% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $17.50 |
Price Target Difference | 77.04% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
The Joint has an Altman Z-Score of 2.13 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.13 |
Piotroski F-Score | 5 |